Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terra Warner

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
BPI26-008: Optimizing Germline Genetic Referral and Testing Rates for High-Grade Serous Ovarian Cancer PatientsTerra Warner, Amy Laughlin, Heather Owen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
BPI26-008: Optimizing Germline Genetic Referral and Testing Rates for High-Grade Serous Ovarian Cancer PatientsTerra Warner, Amy Laughlin, Heather Owen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
QIM26-312: A Scalable Model for Oncology Home Leuprolide InjectionsNirja Shah, Karla Bowen, Danielle Darden, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
QIM26-312: A Scalable Model for Oncology Home Leuprolide InjectionsNirja Shah, Karla Bowen, Danielle Darden, et al.
JCO Oncology Practice|June 9, 2025
Electronic Health Record-Enabled Identification and Targeted Multipronged Intervention to Reduce Readmission and Length of Stay Among Patients With Metastatic CancerMichelle M Chin, Andrew D Nguyen, Ashlie Jones, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
BPI26-008: Optimizing Germline Genetic Referral and Testing Rates for High-Grade Serous Ovarian Cancer PatientsTerra Warner, Amy Laughlin, Heather Owen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
BPI26-008: Optimizing Germline Genetic Referral and Testing Rates for High-Grade Serous Ovarian Cancer PatientsTerra Warner, Amy Laughlin, Heather Owen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
QIM26-312: A Scalable Model for Oncology Home Leuprolide InjectionsNirja Shah, Karla Bowen, Danielle Darden, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
QIM26-312: A Scalable Model for Oncology Home Leuprolide InjectionsNirja Shah, Karla Bowen, Danielle Darden, et al.
JCO Oncology Practice|June 9, 2025
Electronic Health Record-Enabled Identification and Targeted Multipronged Intervention to Reduce Readmission and Length of Stay Among Patients With Metastatic CancerMichelle M Chin, Andrew D Nguyen, Ashlie Jones, et al.
Pageof 1